← Back to Screener
A

ADIL

Adial Pharmaceuticals, Inc
Biotech / PharmaScore: 92/10018 Active Signals📋 Full Profile
A
92

What is the current ADIL catalyst setup?

ADIL is tracked by BiotechSigns with a current catalyst score of 92/100 and grade A. The page summarizes 18 active signals, including 0 PDUFA, 1 insider buying, and 1 clinical trial signals, with data refreshed on 2026-06-03.

Analyst Summary
Verified 2026-04-11

Adial Pharmaceuticals, Inc Common Stock (ADIL) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

ADIL has 6 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources

  1. SEC EDGAR · 0001513525 (2026-04-11) ↗
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
👤
INSIDER
438 Form 4 filings (last 30d)
100
↗
🔬
CLINICAL
24 active trials · Ph3: 4 · Ph2: 6
100
↗
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
SHORT INTERESTSqueeze: MODERATE▼ DECREASING
% of Float
33.78%
Days to Cover
1.0d
Chg (period)
-24.86%
↗ full detail in Dilution tab
Signal Summary
PDUFA0
Insider1
Clinical1
Data Sources
Dilution◌ LOADING
Sentiment◌ LOADING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE